Revolutionizing Surgical Precision: Galen Robotics Secures $15M in Series B Funding

Galen Robotics is thrilled to announce that we have successfully raised $15 million in our latest funding round, a pivotal step in our mission to transform the landscape of surgical interventions. Our company is revolutionizing the medical field by developing an innovative single-platform solution designed to assist surgeons across various disciplines with minimal disruption to their existing workflows. By leveraging our advanced cooperative control paradigm, we aim to eliminate hand tremor, thereby unlocking new levels of precision in minimally invasive surgeries. This funding will enable us to enhance our research and development efforts, focusing on expanding our technology's applicability to otolaryngology, head and neck surgery, and tissue reconstruction procedures—fields where the demands for accuracy and control are exceptionally high. Previously, many surgical interventions were thought to be beyond human capability; however, with Galen Robotics’ advancements, we are poised to make these complex procedures more accessible and achievable. The support from our investors not only validates the innovative nature of our approach but also strengthens our resolve to deliver state-of-the-art robotic solutions that empower surgeons and improve patient outcomes. As we move forward, this funding will play a crucial role in accelerating our product development and bringing our vision of a safer, more efficient surgical environment closer to reality. We are excited about the journey ahead and grateful to our investors for their belief in our mission to reshape the surgical experience for both healthcare providers and patients alike.